Page last updated: 2024-12-08

flaviolin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

flaviolin: isolated from mutants of Wangiella dermatitidis; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

flaviolin : A hydroxy-1,4-naphthoquinone that is 1,4-naphthoquinone having three hydroxy substituents placed at the 2-, 5- and 7-positions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID160478
CHEMBL ID1232770
CHEBI ID42646
SCHEMBL ID703160
SCHEMBL ID2315695
MeSH IDM0123454

Synonyms (20)

Synonym
CHEMBL1232770
flaviolin
2,5,7-trihydroxynaphthoquinone
DB02521
2,5,7-trihydroxy-1,4-naphthalenedione
4,5,7-trihydroxynaphthalene-1,2-dione
CHEBI:42646 ,
2,5,7-trihydroxynaphthalene-1,4-dione
479-05-0
C18012
1,4-naphthalenedione, 2,5,7-trihydroxy-
th7zc8j7oe ,
unii-th7zc8j7oe
SCHEMBL703160
SCHEMBL2315695
bdbm50487951
2,5,7-trihydroxy-1,4-naphthoquinone
2,5,7-trihydroxy-1,4-dihydronaphthalene-1,4-dione
Q27093505
DTXSID60963960

Research Excerpts

Overview

Flaviolin is a spontaneous oxidation product of 1,3,6,8-tetrahydroxynaphthalene (THN) It is biosynthesized in bacteria by a chalcone synthase-like (CS-like) type III polyketide synthase (PKS)

ExcerptReferenceRelevance
"Flaviolin is a spontaneous oxidation product of 1,3,6,8-tetrahydroxynaphthalene (THN), which is biosynthesized in bacteria by a chalcone synthase-like (CS-like) type III polyketide synthase (PKS)."( Identification and cloning of a type III polyketide synthase required for diffusible pigment biosynthesis in Saccharopolyspora erythraea.
Blackaby, AP; Cortés, J; Foster, G; Rudd, BA; Velasco, J; Wilkinson, B, 2002
)
1.04
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (8.70)18.7374
1990's0 (0.00)18.2507
2000's11 (47.83)29.6817
2010's4 (17.39)24.3611
2020's6 (26.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.83 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index5.18 (4.65)
Search Engine Demand Index53.49 (26.88)
Search Engine Supply Index3.00 (0.95)

This Compound (29.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]